mHealth App and Booklets for Sickle Cell Disease
This study is testing if an mHealth app (a health app on your phone) combined with booklets can help adults with sickle cell disease (SCD) manage their condition better. The app and booklets contain patient-friendly guidelines for SCD. We want to see if using these tools can reduce how often people with SCD need to go to the hospital or emergency room. You might be able to join if you are an adult (18 years or older) with a diagnosis of SCD (Hgb SS, SC, or Sβ-thal), have been receiving care at an SCD clinic for the past year, and can speak and understand English. The study will measure healthcare use over 12 months to see if the app and booklets are effective. The study is currently recruiting participants.
- Study design
- This study is a randomized controlled trial involving 287 participants. It compares the mHealth app + booklets to standard care.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 12 months to measure healthcare utilization.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
At a glance
Conditions
Where it's being run
4 sites across 4 statesStudy leadership
- Robert M Cronin, MD, MS · PRINCIPAL_INVESTIGATOR · Ohio State University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Acute healthcare utilization12 month
The investigators will measure a count of the # ER visits, # of hospitalizations, and # of day hospital visits (infusion center visits)